Eva Petkova
#108,221
Most Influential Person Now
Bulgarian-American biostatistician
Eva Petkova's AcademicInfluence.com Rankings
Eva Petkovamathematics Degrees
Mathematics
#7001
World Rank
#9602
Historical Rank
Statistics
#888
World Rank
#980
Historical Rank
Download Badge
Mathematics
Eva Petkova's Degrees
- Bachelors Mathematics Sofia University
Similar Degrees You Can Earn
Why Is Eva Petkova Influential?
(Suggest an Edit or Addition)According to Wikipedia, Eva Petkova is a Bulgarian-American biostatistician interested in the application of statistics to psychiatry, and known for her research on regression model comparison, brain imaging, and mental disorders. She is a professor of population health and of child and adolescent psychology at the New York University School of Medicine, and a research scientist at the Nathan Kline Institute for Psychiatric Research.
Eva Petkova's Published Works
Published Works
- Statistical Methods for Comparing Regression Coefficients Between Models (1995) (1673)
- A developmental approach to complex PTSD: childhood and adult cumulative trauma as predictors of symptom complexity. (2009) (1207)
- The resting brain: unconstrained yet reliable. (2009) (896)
- The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry (2012) (623)
- Treatment for PTSD related to childhood abuse: a randomized controlled trial. (2010) (524)
- A multisite study of the clinical diagnosis of different autism spectrum disorders. (2012) (486)
- Research Paper: A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study (2009) (339)
- A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy (2008) (321)
- Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. (2004) (305)
- A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. (2008) (239)
- Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD. (2015) (236)
- Association of Psychiatric Disorders With Mortality Among Patients With COVID-19. (2021) (222)
- Examining Autistic Traits in Children with ADHD: Does the Autism Spectrum Extend to ADHD? (2010) (212)
- A Pilot Placebo-Controlled Study of Fluvoxamine for Pathological Gambling (2002) (204)
- Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. (2016) (190)
- Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial. (2013) (178)
- Research Paper: A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus (2006) (177)
- Response versus remission in obsessive-compulsive disorder. (2006) (169)
- Early Childhood Family Intervention and Long-term Obesity Prevention Among High-risk Minority Youth (2012) (159)
- Promoting effective parenting practices and preventing child behavior problems in school among ethnically diverse families from underserved, urban communities. (2011) (156)
- AN EXAMINATION OF THE INFLUENCE OF A SEQUENTIAL TREATMENT ON THE COURSE AND IMPACT OF DISSOCIATION AMONG WOMEN WITH PTSD RELATED TO CHILDHOOD ABUSE (2012) (144)
- Decomposing Intra-Subject Variability in Children with Attention-Deficit/Hyperactivity Disorder (2008) (141)
- Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change. (1999) (138)
- Are there differences between women's and men's antidepressant responses? (2002) (135)
- A global needs assessment in times of a global crisis: world psychiatry response to the COVID-19 pandemic (2020) (134)
- Statistical Methods for Analyzing Collapsibility in Regression Models (1992) (128)
- Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. (2005) (125)
- Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. (2012) (125)
- Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization. (2014) (125)
- D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. (2015) (119)
- Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. (1997) (119)
- Post‐treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder (2004) (119)
- Chronological milestones to guide drug change. When should clinicians switch antidepressants? (1996) (114)
- A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. (2000) (106)
- A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications (2021) (103)
- Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. (2003) (102)
- Predictors of relapse in a prospective study of fluoxetine treatment of major depression. (2006) (100)
- When should a trial of fluoxetine for major depression be declared failed? (2003) (94)
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms (2018) (90)
- A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder (2008) (72)
- A Population-Level Approach to Promoting Healthy Child Development and School Success in Low-Income, Urban Neighborhoods: Impact on Parenting and Child Conduct Problems (2015) (71)
- Cluster (School) RCT of ParentCorps: Impact on Kindergarten Academic Achievement (2013) (71)
- Cognitive‐behavioral treatment of persistent functional somatic complaints and pediatric anxiety: an initial controlled trial (2011) (69)
- Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice (2015) (66)
- Can school counselors deliver cognitive-behavioral treatment for social anxiety effectively? A randomized controlled trial. (2016) (65)
- Dissociation, childhood trauma, and ataque de nervios among Puerto Rican psychiatric outpatients. (2002) (62)
- Cognitive Behavioral Therapy and Fluoxetine for Binge Eating Disorder: Two‐year Follow‐up (2007) (61)
- Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. (2000) (59)
- Substance Use During Sex and Sensation Seeking as Predictors of Sexual Risk Behavior Among HIV+ and HIV− Gay Men (1997) (58)
- Some Statistical Issues in the Analyses of Data From Longitudinal Studies of Elderly Chronic Care Populations (2002) (58)
- Pooling Data From Individual Clinical Trials in the COVID-19 Era. (2020) (56)
- Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. (1997) (56)
- Short-term test–retest reliability of resting state fMRI metrics in children with and without attention-deficit/hyperactivity disorder (2015) (55)
- A Reappraisal of the U.S. Clinical Trials of Post-Treatment Lyme Disease Syndrome (2012) (53)
- Illness-specific anxiety: implications for functioning and utilization of medical services in adolescents with inflammatory bowel disease. (2011) (52)
- Menstrual functioning and psychopathology in a county-wide population of high school girls. (2002) (51)
- Effects of ParentCorps in Prekindergarten on Child Mental Health and Academic Performance: Follow-up of a Randomized Clinical Trial Through 8 Years of Age. (2016) (50)
- Sleep oscillation-specific associations with Alzheimer’s disease CSF biomarkers: novel roles for sleep spindles and tau (2019) (50)
- Response time intra-subject variability: commonalities between children with autism spectrum disorders and children with ADHD (2014) (50)
- Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. (2005) (48)
- Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes (2016) (48)
- A Double-Masked, Placebo-Controlled Study of Fluoxetine for Hypochondriasis (2008) (46)
- Asthma Self-Management is Sub-Optimal in Urban Hispanic and African American/Black Early Adolescents with Uncontrolled Persistent Asthma (2012) (46)
- On Distance‐Based Permutation Tests for Between‐Group Comparisons (2010) (45)
- A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. (2007) (45)
- Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder (2018) (43)
- Reply to Allison: More on Comparing Regression Coefficients (1995) (42)
- Patient characteristics as a moderator of post-traumatic stress disorder treatment outcome: combining symptom burden and strengths (2016) (41)
- A Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acids in Tourette’s Disorder (2012) (40)
- Longitudinal effects of personality disorders on psychosocial functioning of patients with major depressive disorder. (2007) (40)
- A comparative study of variable selection methods in the context of developing psychiatric screening instruments (2014) (40)
- Placebo run-in period in studies of depressive disorders (1998) (39)
- Profiling Placebo Responders by Self-Consistent Partitioning of Functional Data (2003) (39)
- Decreased recall of primacy words predicts cognitive decline. (2013) (36)
- SYMPOSIUM ON APPLIED REGRESSION Statistical Methods for Comparing Regression Coefficients between Models1 (1995) (34)
- A Method to Quantify Rater Bias in Antidepressant Trials (2000) (33)
- Controlled cross-over study in normal subjects of naloxone-preceding-lactate infusions; respiratory and subjective responses: relationship to endogenous opioid system, suffocation false alarm theory and childhood parental loss (2010) (33)
- Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD (2014) (33)
- Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. (2009) (32)
- Response-Time Variability Is Related to Parent Ratings of Inattention, Hyperactivity, and Executive Function (2011) (32)
- Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients (2021) (32)
- Neurophysiological Effects of Bitopertin in Schizophrenia (2017) (30)
- Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer’s disease (AD) (2015) (30)
- Treatment decisions based on scalar and functional baseline covariates (2015) (30)
- Longitudinal comparison of depressive personality disorder and dysthymic disorder. (2005) (29)
- Development and evaluation of a multimodal marker of major depressive disorder (2018) (29)
- Interpreting meta‐regression: application to recent controversies in antidepressants’ efficacy (2013) (28)
- Treatment preferences of psychotherapy patients with chronic PTSD. (2016) (25)
- Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study (2017) (24)
- Latent regression analysis (2010) (24)
- Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19 (2022) (24)
- Adverse performance effects of acute lorazepam administration in elderly long-term users: Pharmacokinetic and clinical predictors (2015) (23)
- Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder (2016) (23)
- Mentoring in Psychiatric Residency Programs: A Survey of Chief Residents (2009) (23)
- Expression profile analysis of vulnerable CA1 pyramidal neurons in young–Middle‐Aged Ts65Dn mice (2015) (22)
- Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma (2022) (22)
- Optimal Partitioning for Linear Mixed Effects Models: Applications to Identifying Placebo Responders (2010) (21)
- CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation (2018) (20)
- History of sexual trauma moderates psychotherapy outcome for posttraumatic stress disorder (2017) (20)
- Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research. (2008) (19)
- Auditory tasks for assessment of sensory function and affective prosody in schizophrenia. (2014) (17)
- Principal Point Classification: Applications to Differentiating Drug and Placebo Responses in Longitudinal Studies. (2010) (17)
- A multi-site single-blind clinical study to compare the effects of STAIR Narrative Therapy to treatment as usual among women with PTSD in public sector mental health settings: study protocol for a randomized controlled trial (2014) (16)
- EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER (2015) (16)
- Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression (2011) (15)
- A Paradoxical Result in Estimating Regression Coefficients (2014) (14)
- Perceived social support in adults with autism spectrum disorder and attention‐deficit/hyperactivity disorder (2017) (14)
- Influence of human immunodeficiency virus infection on neurological impairment: an analysis of longitudinal binary data with informative drop‐out (1999) (14)
- Long‐term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease (2019) (14)
- Generated effect modifiers (GEM's) in randomized clinical trials. (2017) (13)
- Flexible functional regression methods for estimating individualized treatment rules (2016) (13)
- Constructing treatment decision rules based on scalar and functional predictors when moderators of treatment effect are unknown (2018) (13)
- Implementation of a screen and treat program for child posttraumatic stress disorder in a school setting after a school suicide. (2010) (13)
- The impact of comorbid dysthymic disorder on outcome in personality disorders. (2010) (12)
- Extracting information from functional connectivity maps via function-on-scalar regression (2011) (12)
- The Early Screening for Autism and Communication Disorders: Field-testing an autism-specific screening tool for children 12 to 36 months of age (2021) (12)
- Low frequency oscillations of response time explain parent ratings of inattention and hyperactivity/impulsivity (2012) (11)
- COVID-19 Outcomes in 4712 consecutively confirmed SARS-CoV2 cases in the city of Madrid. (2020) (10)
- A single-index model with multiple-links. (2020) (9)
- Effects of neonatal ethanol on cerebral cortex development through adolescence (2019) (9)
- Long-term follow-up study of patients with refractory obsessive-compulsive disorder. (2008) (9)
- Model misspecification (2008) (9)
- Predicting Potential Placebo Effect in Drug Treated Subjects (2009) (8)
- Prospective individual patient data meta‐analysis: Evaluating convalescent plasma for COVID‐19 (2021) (8)
- Optimising treatment decision rules through generated effect modifiers: a precision medicine tutorial (2019) (8)
- Forming first impressions of others in schizophrenia: Impairments in fast processing and in use of spatial frequency information (2014) (8)
- Hippocampal volume and integrity as predictors of cognitive decline in intact elderly (2016) (8)
- Elucidating Age and Sex-Dependent Association Between Frontal EEG Asymmetry and Depression: An Application of Multiple Imputation in Functional Regression (2021) (7)
- A Bayesian approach to joint modeling of matrix‐valued imaging data and treatment outcome with applications to depression studies (2019) (7)
- Input permutation method to detect active voxels in fMRI study. (2012) (6)
- Ongoing discussion about the US clinical Lyme trials. (2014) (6)
- A constrained single‐index regression for estimating interactions between a treatment and covariates (2020) (6)
- Stratified Psychiatry via Convexity-Based Clustering with Applications Towards Moderator Analysis. (2016) (5)
- Predicting multiscan MRI outcomes in children with neurodevelopmental conditions following MRI simulator training (2021) (5)
- Partitioning of Functional Data for Understanding Heterogeneity in Psychiatric Conditions. (2009) (4)
- Long-Term Follow-Up Study of Patients With Refractory Obsessive-Compulsive Disorder (2008) (4)
- Order test for high-dimensional two-sample means (2012) (4)
- Family- and Neighborhood-Level Factors as Predictors of Conduct Problems in School among Young, Urban, Minority Children (2015) (4)
- Air pollution and hippocampal atrophy in first episode schizophrenia (2020) (4)
- 499. Role of ovarian steroids in modulating mood in premenstrual syndrome (1996) (4)
- Reducing Morbidity And Urgent Health Care Utilization In Urban Pre-adolescents With Asthma: Results Of A Randomized Control Trial Of Asthma: It’s A Family Affair (2010) (4)
- Children and adolescents with Tourette’s disorder in the USA versus Argentina: behavioral differences may reflect cultural factors (2013) (4)
- Order‐Preserving Dimension Reduction Procedure for the Dominance of Two Mean Curves with Application to Tidal Volume Curves (2008) (4)
- A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation* (2022) (3)
- Multiple imputation in functional regression with applications to EEG data in a depression study (2020) (3)
- LATENT CLASS MODELING USING MATRIX COVARIATES WITH APPLICATION TO IDENTIFYING EARLY PLACEBO RESPONDERS BASED ON EEG SIGNALS. (2017) (3)
- The effectiveness of PTSD treatment for adolescents in the juvenile justice system: A systematic review. (2021) (3)
- Models for discrete data, revised edition. Daniel Zelterman, Oxford University Press Inc., New York, 2006. No. of pages: x + 285. Price: $50.00. ISBN: 0-19-856701-4 (2007) (3)
- Predicting multimodal MRI outcomes in children with neurodevelopmental conditions following MRI simulator training (2021) (2)
- Reply to "A Paradoxical Result in Estimating Regression Coefficients" (2015) (2)
- The Application of Nof-1 Treatment Trials in Schizophrenia : A Systematic Review (2018) (2)
- Robust index of confidence weighted learning for optimal individualized treatment rule estimation (2021) (2)
- Functional additive models for optimizing individualized treatment rules (2021) (2)
- Comment: Problems with Using Auxiliary Information to Correct for Omitted Variables when Estimating the Effect of Lead on IQ (1998) (2)
- Modelling Placebo Response via Infinite Mixtures. (2010) (2)
- Establishing the Reliability of Amplitude Measures for Spontaneous Fluctuations in the Resting Brain (2009) (1)
- A sparse additive model for treatment effect-modifier selection. (2020) (1)
- The integrity of the research record: a mess so big and so deep and so tall (2022) (1)
- Extracting scalar measures from functional data with applications to placebo response. (2021) (1)
- Predictors of cognitive decline in elderly depressives (2015) (1)
- A Single-Index Model With a Surface-Link for Optimizing Individualized Dose Rules (2020) (1)
- A comparison of hippocampal volume and integrity: Which is the better predictor of cognitive decline? (2015) (1)
- Reply (2015) (1)
- S95. Loudness Dependency of Auditory Evoked Potentials (LDAEP) as a Differential Predictor of Antidepressant Treatment Response in Major Depressive Disorder (MDD): Results From the Sertraline/Placebo-Controlled EMBARC Study (2018) (0)
- Sufficient Dimension Reduction for Interactions (2020) (0)
- ARE PLASMA AMYLOID-β LEVELS IN LATE-LIFE MAJOR DEPRESSION A MARKER OF HEIGHTENED AD RISK? (2019) (0)
- Performance on Meeting Targets for Multiple Cardiovascular Disease-Related Risk Factors in Small Independent Practices and Federally Qualified Health Centers (2017) (0)
- A constrained sparse additive model for treatment effect-modifier selection (2020) (0)
- Double-Blind Placebo-Controlled Study L-Dopa Modulates Functional Connectivity in Striatal Cognitive and Motor Networks : A (2008) (0)
- Letter to the Editor (2019) (0)
- Functional Data Analysis Issues for Identifying Placebo Response in Drug Treated Subjects (2003) (0)
- 6.64 AN INITIAL INVESTIGATION OF BRAIN FUNCTIONAL REORGANIZATION FOLLOWING ORGANIZATIONAL SKILLS TRAINING IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (2016) (0)
- Circulating Aβ40 influences plasma BDNF levels and white matter integrity (2012) (0)
- Confidence in the treatment decision for an individual patient: strategies for sequential assessment (2023) (0)
- Modeling Strategies for Developing Treatment Response Indices (2013) (0)
- Unsupervised Bayesian classification for models with scalar and functional covariates (2022) (0)
- Identification of Placebo Responders Among Drug-Treated Subjects (2003) (0)
- A Pilot Placebo-Controlled for Pathological Gambling Study of Fluvoxamine (2002) (0)
- P.3.01 Slow frequency oscillations of response-time intra-subject variability in children with ADHD (2009) (0)
- Africa requires massive funding to help stem health crisis experts tell UN panel. (2001) (0)
- The Role Of Family Functioning And Asthma-Related Anxiety On Prevention And Management Of Asthma In Urban Early Adolescents With Uncontrolled Asthma (2012) (0)
- Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer’s disease (AD) (2014) (0)
- Multiple Domain and Multiple Kernel Outcome-Weighted Learning for Estimating Individualized Treatment Regimes (2022) (0)
- Canonical k-Means Clustering for Functional Data (2013) (0)
- Constrained functional additive models for estimating interactions between a treatment and functional covariates (2020) (0)
- Package ‘simml’ (2021) (0)
- Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring (2023) (0)
- Bayesian index models for heterogeneous treatment effects (2022) (0)
- Asthma Self-Management And Responsbility In Early Adolescents (2011) (0)
- Effects of neonatal ethanol on cerebral cortex development through adolescence (2019) (0)
- Hippocampal Subfield Volumes Predict Disengagement from Maintenance Treatment in First Episode Schizophrenia (2022) (0)
- Clustering and Partitioning of Functional Data for Understanding the Heterogeneity in Psychiatric Diagnosis (2008) (0)
- 176. Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder (2018) (0)
This paper list is powered by the following services:
Other Resources About Eva Petkova
What Schools Are Affiliated With Eva Petkova?
Eva Petkova is affiliated with the following schools: